Medidata Solutions Achieves 26th Quarter of Consecutive Growth



    Company Signs 13 New Global Customers in Q2, Continues to Drive EDC
Industry through Strategic Partnerships and Market Recognition

    NEW YORK, September 12 /CNW/ - Medidata Solutions, a global leader in
electronic data capture (EDC), management and reporting solutions, today
announced the company's 26th quarter of consecutive growth. Medidata completed
the quarter with an 81.5 percent year over year revenue growth, signing 13 new
customers in the U.S., Europe and Japan and 15 follow-on contracts from
existing customers.

    Nine of Medidata's 13 new customers this quarter were due to the success
of its ASPire to Win partner program, which enables contract research
organizations (CROs) to meet sponsor demand for Medidata Rave(R) and offer the
platform in-house by building and deploying studies with Rave certified
resources. Additionally, 17 new trials were initiated through existing ASPire
to Win partners in the second quarter alone. During Q2, Medidata entered into
a new ASPire to Win partnership with Chiltern Ltd to implement Medidata Rave
to manage electronic clinical trial data for pharmaceutical and biotechnology
sponsors around the world.

    Additional highlights from Q2 include:

    --  Growing European presence with H. Lundbeck A/S' selection of Medidata
Rave as its EDC, management and reporting solution to manage several Phase
II-IV trials with the goal of conducting 10 or more studies in Rave each year;

    --  Growth in biotech with the implementation of Medidata Rave with
California-based BioMarin Pharmaceutical;

    --  Continued relationships with pharmaceutical companies Sucampo
Pharmaceuticals, Inc. and SuperGen, Inc;

    --  Strategic technology partnership with SAS, integrating Medidata Rave
with SAS Drug Development to enable data streamlined access to study data on
one uniform, regulatory-compliant data management path.

    In order to meet increased customer demand in 2007, Medidata Solutions
increased its staff 29 percent across R&D, services, sales and strategic
alliances and corporate areas throughout the U.S., Europe and Japan.
Medidata's executives continued to drive industry thought-leadership through a
range of efforts:

    --  United BioSource Corporation, Medidata and Tessella began the first
in a series of six educational webinars, entitled "Enabling Adaptive Clinical
Trials."

    --  Through partnering with Fast Track Systems, Medidata hosted a webinar
on integrating trial design and EDC study build for participants.

    --  Medidata, invivodata and CDISC presented a DIA-sponsored webinar on
ePRO and EDC integration prior to the DIA Annual Meeting.

    --  Vice President of Global Regulatory Affairs and Quality Assurance
Earl Hulihan was honored at the DIA Annual Meeting with the DIA Founders
Service Award, recognizing his lifelong contributions to medicine and
regulatory science.

    --  Medidata executives delivered presentations at industry events in Q2
including 2007 CDISC European Interchange, 43rd Annual DIA Meeting, 23rd
Annual SQA Meeting, EDC & Beyond, SMi's 2007 Phase IV Conference, and ViB's
7th Annual e-Clinical Trials 2007.

    "We're pleased to attribute our continued growth this quarter to a
significant number of follow-on contracts with existing customers, new sponsor
commitments to Medidata Rave, and additional clients brought on as a result of
our partnerships with the industry's leading CROs," said Tarek Sherif, CEO of
Medidata Solutions. "Through our strategic addition of key global customers,
partners and Medidata staff, we've greatly increased our market presence this
quarter and look forward to further success through the second half of the
year."

    About Medidata Solutions Worldwide

    Medidata Solutions helps the world's leading pharmaceutical,
biotechnology, medical device and research organizations maximize the value of
their clinical research investments. Innovative process design, technology and
services streamline clinical trials by providing early visibility to reliable
clinical data - the lifeblood of every research organization. Working with
companies and institutions both large and small, Medidata Solutions helps
clinical researchers safely accelerate the process of bringing life-enhancing
treatments to market - on six continents and in more than 80 countries.
Medidata Solutions brings significant value to its broad client base with deep
clinical experience and expertise in more than 20 therapeutic areas, projects
in Phase I, II, III, IV, registries and surveillance, and studies with
thousands of investigators and tens-of-thousands of subjects. For more
information, please visit www.mdsol.com.




For further information:

For further information: Lois Paul & Partners Susan Lombardo,
781-782-5767 Susan_Lombardo@lpp.com

Organization Profile

MEDIDATA SOLUTIONS WORLDWIDE

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890